UROGEN PHARMA LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.19 USD | -2.94% |
|
-2.66% | -12.07% |
| 06-03 | UroGen Pharma Appoints David Lin as New Chief Commercial Officer | CI |
| 05-14 | Oppenheimer Lowers UroGen Pharma Price Target to $32 From $34, Maintains Outperform Rating | MT |
- Stock Market
- Equities
- URGN Stock
- Charts UroGen Pharma Ltd.
- Static Chart